Matinas BioPharma
MTNB
$0.16
Share price
-0.06%
Change (1 day)
-61.00%
Change (1 year)
Categories
Matinas BioPharma (MTNB) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $5.05 M
According to Matinas BioPharma's latest financial reports the company's total liabilities are $5.05 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Matinas BioPharma - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $8.18 M | -7.36% |
| 2021-12-31 | $8.83 M | 22.05% |
| 2020-12-31 | $7.23 M | 0.67% |
| 2019-12-31 | $7.18 M | 89.1% |
| 2018-12-31 | $3.8 M | 1.6% |
| 2017-12-31 | $3.74 M | 40.33% |
| 2016-12-31 | $2.66 M | 14.26% |
| 2015-12-31 | $2.33 M | 105.87% |
| 2014-12-31 | $1.13 M | 31.97% |
| 2013-12-31 | $0.85 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | 338.26% | 🇺🇸 USA |